Intelligent Bio Solutions Inc. - Common Stock (INBS)
1.5800
0.00 (0.00%)
Intelligent Bio Solutions Inc. is a biotechnology company focused on delivering innovative solutions in the field of drug testing and biomonitoring
The company specializes in developing non-invasive tests that leverage advanced technology to provide rapid, accurate, and reliable results. By utilizing its proprietary platform, Intelligent Bio Solutions aims to enhance workplace safety, improve public health monitoring, and facilitate more efficient drug testing processes across various sectors, including healthcare and law enforcement. Their commitment to innovation positions them at the forefront of the evolving landscape of bioanalytics.
PALM BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Due to the expanding consumption of illicit drugs & alcohol across the globe the Drug Screening market is poised to grow substantially in the coming years. Drug abuse and alcohol consumption are growing worldwide. According to the World Drug Report 2023, in 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The number of users grew from 240 million in 2011 to 296 million in 2021 or 5.8% of the global population aged 15-64. This is a 23% increase, partly due to population growth. Other drugs like Cannabis the second most used drug, with an estimated 219 million users i.e. 4.3% of the global adult population in 2021. In 2021, according to the US Department of Transportation, National Highway Traffic Safety Administration (NHTSA), 13,384 people died in alcohol-impaired driving crashes, i.e. a 14% rise from last year. A report from MarketsAndMarkets projected that: “The global drug screening market, valued at US$7.7 billion in 2023, is forecasted to grow at a robust CAGR of 16.6%, reaching US$9.1 billion in 2024 and an impressive US$19.5 billion by 2029.North America dominates the drug screening market. This market is projected to reach USD 9.3 billion by 2029, at a CAGR of 16.4% during the forecast period. The expanding consumption of illicit drugs & alcohol will advance raise the development of drug screening products & services on the road, thereby driving the overall market growth.” Active companies in news today include: Intelligent Bio Solutions Inc. (NASDAQINBS), Cardio Diagnostics Holdings, Inc. NASDAQ: CDIONASDAQCDIO)(NASDAQ: BIAFNASDAQBIAF, Trinity Biotech plc (NASDAQ: TRIBNASDAQ), SOBR Safe, Inc. (NASDAQ: SOBRSOBR).
Intelligent Bio Solutions (NASDAQINBS) is leading the way in developing advanced diagnostic technologies. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.
NEW YORK - (NewMediaWire) - November 1, 2024 - Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a strategic partnership with B2i Digital to launch an investor-focused marketing campaign. B2i Digital will employ advanced digital marketing strategies to raise awareness of INBS’ patented drug screening technology, which offers a fast, non-invasive, and efficient alternative to traditional drug tests.
Groundbreaking contracts and technological advancements across space exploration, environmental monitoring, high-grade mineral discovery, military and healthcare solutions, these five companies are setting the stage for significant market growth. Take a look now!
Intelligent Bio Solutions stock surges with increased trading volume, driven by progress on its FDA 510(k) submission. The company, specializing in non-invasive testing, advances clinical trials and reports significant growth in drug screening system installations.
These five stocks are generating significant attention and could offer strong opportunities for growth across sectors like biotech, tech, energy, and medical devices.
As investors seek opportunities in a dynamic market, several key stocks—Intelligent Bio Solutions, Nano One, Power Nickel, MicroAlgo, and Kaival Brands—are demonstrating significant growth potential driven by strategic initiatives and sector innovations.
Here are five companies in the spotlight, under $5 across technology, biomedical, healthcare, aerospace, commercial real estate and medical sectors, demonstrating strong market trends, volume, and awareness:
In today’s fast-paced work environment, ensuring that employees are "Fit to Work" is essential for maintaining safety and productivity. Intelligent Bio Solutions Inc. (NASDAQINBS) is leading the charge with its "Fit to Work" mission, a commitment to ensuring that employees are physically and mentally prepared to perform their jobs safely and effectively. Central to this mission is the INBS Drug Reader, a non-invasive drug testing tool that plays a vital role in promoting workplace safety, trust, and accountability.
As workplaces prioritize safety and efficiency, drug testing remains essential. Traditional methods, however, can be costly, slow, and invasive. Intelligent Bio Solutions Inc. (NASDAQINBS) is redefining this process with the INBS Drug Reader, a cutting-edge solution that sets a new standard for workplace drug testing.
Here are five companies recently in the spotlight, ranging from under $1 to $9, across technology, biomedical, healthcare, precious metals, and energy sectors, demonstrating strong market trends, volume, and awareness:
Intelligent Bio Solutions Inc. (NASDAQINBS) is transforming how companies approach this challenge with the introduction of the INBS Drug Reader, a groundbreaking tool designed to enhance workplace safety and accountability. Workplace safety is a top priority for industries where even a minor lapse in judgment or concentration can have serious consequences. In sectors such as manufacturing, construction, and logistics, ensuring that employees are fit for duty is essential. However, traditional drug testing methods often fall short, leading to delays in decision-making and potential risks to safety.
In the rapidly evolving biotech sector, a few standout companies are pushing boundaries and setting new standards. From Intelligent Bio Solutions' innovative drug testing technology to PMV Pharmaceuticals' promising clinical trial advancements, these trailblazers are not just making headlines—they're shaping the future of healthcare while improving the workplace. Discover how these five companies are leading the charge in innovation, with significant developments that could impact industries and lives worldwide.
These companies are redefining market potential with innovation-driven growth and strategic advancements, presenting attractive opportunities for savvy investors seeking to capitalize on emerging trends and market dynamics.
Here are five companies under $2 utilizing Artificial Intelligence (AI) in technology, biomedical, healthcare, wireless communications, and energy sectors, demonstrating strong market trends and increasing awareness:
In July 2024, Intelligent Bio Solutions Inc. (Nasdaq: INBS) revealed that three UK-based manufacturers adopted its Fingerprint Drug Screening System, renowned for its fast, intelligent, and non-invasive drug detection through fingertip sweat. This innovation’s biocompatibility has propelled it towards FDA clearance, with plans for a U.S. launch in 2025.
